Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement

被引：0
|
作者：
Taryn A. G. Quinlan
Brock Schroeder
Sue Kwon
Jane F. Barlow
Michael S. Sherman
Heather D. Anderson
Garth Wright
R. Brett McQueen
机构：
[1] University of Colorado Anschutz Medical Campus,Department of Health Systems, Management and Policy
[2] Illumina,Department of Clinical Pharmacy
[3] Inc.,Department of Population Medicine
[4] University of Colorado Anschutz Medical Campus,Skaggs School of Pharmacy and Pharmaceutical Sciences
[5] Real Endpoints,undefined
[6] LLC,undefined
[7] Harvard Pilgrim Health Care,undefined
[8] Harvard Medical School,undefined
[9] University of Colorado,undefined
来源：
PharmacoEconomics - Open | 2021年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：449 / 458
页数：9
相关论文
共 50 条
  • [21] Experience of a Performance-Based Risk-Sharing Arrangement for the Treatment of Rheumatoid Arthritis With Certolizumab Pegol
    Buela, Gabriela
    Di Giuseppe, L. A.
    Zacariaz Hereter, J. B.
    Adrian Terrasa, Sergio
    Garfi, L. A.
    Soriano, E. R.
    [J]. INTERNATIONAL JOURNAL OF INTEGRATED CARE, 2022, 22
  • [22] Non-invasive prenatal testing: impact on invasive prenatal diagnosis at a mainland Chinese tertiary medical center
    Li, Dong-Zhi
    Zhen, Li
    Pan, Min
    Han, Jin
    Yang, Xin
    Ou, Yan-Mei
    [J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2016, 29 (21): : 3539 - 3541
  • [23] The impact of non-invasive prenatal testing on the practice of maternal fetal medicine
    Friel, Lara
    Czerwinski, Jennifer
    Singletary, Claire
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (01) : S238 - S238
  • [24] Approach and Management of Pregnancies with Risk Identified by Non-Invasive Prenatal Testing
    Gug, Miruna
    Ratiu, Adrian
    Andreescu, Nicoleta
    Farcas, Simona
    Laitin, Sorina
    Gug, Cristina
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (04):
  • [25] International experience with performance-based risk-sharing arrangements: implications for the Chinese innovative pharmaceutical market
    Xu, Weiwei
    Wu, Jing
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2020, 36 (05) : 486 - 491
  • [26] AGREEMENT BETWEEN FDA APPROVED DRUG LABEL AND PERFORMANCE BASED RISK-SHARING ARRANGEMENT ENDPOINTS
    Pham, N. N.
    Carlson, J. J.
    [J]. VALUE IN HEALTH, 2018, 21 : S119 - S119
  • [27] A decade of non-invasive prenatal screening in Australia: National impact on prenatal screening and diagnostic testing
    Hui, Lisa
    Halliday, Jane
    [J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2023, 63 (02): : 264 - 267
  • [28] ISUOG Consensus Statement on the Impact of Non-invasive Prenatal Testing (NIPT) on Prenatal Ultrasound Practice
    Salomon, L. J.
    Alfirevic, Z.
    Audibert, F.
    Kagan, K. O.
    Paladini, D.
    Yeo, G.
    Raine-Fenning, N.
    [J]. ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2014, 218 (06): : 242 - 243
  • [29] Budget impact of incorporating non-invasive prenatal testing in prenatal screening for Down syndrome in Turkey
    Okem, Zeynep Guldem
    Orgul, Gokcen
    Kasnakoglu, Berna Tari
    Cakar, Mehmet
    Beksac, Mehmet Sinan
    [J]. HEALTH POLICY AND TECHNOLOGY, 2019, 8 (04) : 402 - 407
  • [30] The psychological impact of receiving an incidental finding with Non-Invasive Prenatal Testing (NIPT)
    Bakkeren, I. M.
    Henneman, L.
    Bekker, M. N.
    van Vliet-Lachotzki, E. H.
    Galjaard, R. H.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 792 - 792
12345